Skip to main navigation

Main navigation

About Us
Commitments
- Innovation Hub
Products
Partnerships
- Grants
- Partnerships for the Future
News
- In The News
- Archive
Events
Investors
Careers

Home
Investors
In the News
Archive
Events

Pacira in the News

Recent News

Pacira Announces EXPAREL Distribution Agreement with Eurofarma in Latin America

06/22/21

Pacira BioSciences Reports Preliminary Net Product Sales of $42.2 Million for May 2021

06/08/21

Pacira BioSciences Announces Top-line Results from Phase 3 STRIDE Study Evaluating EXPAREL as a Lower Extremity Nerve Block

05/26/21

Pacira BioSciences to Present at the 2021 Jefferies Virtual Healthcare Conference

05/25/21

Pacira BioSciences Announces Notice of Allowance of New Patent for EXPAREL

05/18/21

Browse the press release archive

Shareholder Tools

Print Page
RSS Feeds
Email Alerts

Contact Us
Legal
Site Map
Privacy Notice

EXPAREL^® (bupivacaine liposome injectable suspension), the EXPAREL logo, iovera^o, the iovera^o logo, Pacira, and the Pacira logo are registered trademarks of Pacira BioSciences, Inc. All other trademarks referenced herein are the property of their respective owners.